268 related articles for article (PubMed ID: 24668188)
1. Recent trends in drug delivery system using protein nanoparticles.
Sripriyalakshmi S; Jose P; Ravindran A; Anjali CH
Cell Biochem Biophys; 2014 Sep; 70(1):17-26. PubMed ID: 24668188
[TBL] [Abstract][Full Text] [Related]
2. Virus-based nanocarriers for drug delivery.
Ma Y; Nolte RJ; Cornelissen JJ
Adv Drug Deliv Rev; 2012 Jun; 64(9):811-25. PubMed ID: 22285585
[TBL] [Abstract][Full Text] [Related]
3. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
[TBL] [Abstract][Full Text] [Related]
4. Engineering particles for therapeutic delivery: prospects and challenges.
Yan Y; Such GK; Johnston AP; Best JP; Caruso F
ACS Nano; 2012 May; 6(5):3663-9. PubMed ID: 22545561
[TBL] [Abstract][Full Text] [Related]
5. Recent advancement of gelatin nanoparticles in drug and vaccine delivery.
Sahoo N; Sahoo RK; Biswas N; Guha A; Kuotsu K
Int J Biol Macromol; 2015 Nov; 81():317-31. PubMed ID: 26277745
[TBL] [Abstract][Full Text] [Related]
6. Nanosystem drug targeting: Facing up to complex realities.
Ruenraroengsak P; Cook JM; Florence AT
J Control Release; 2010 Feb; 141(3):265-76. PubMed ID: 19895862
[TBL] [Abstract][Full Text] [Related]
7. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
Hunter AC; Elsom J; Wibroe PP; Moghimi SM
Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticulate drug delivery systems for cancer chemotherapy.
Saha RN; Vasanthakumar S; Bende G; Snehalatha M
Mol Membr Biol; 2010 Oct; 27(7):215-31. PubMed ID: 20939772
[TBL] [Abstract][Full Text] [Related]
9. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
Elzoghby AO
J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy.
Gindy ME; Prud'homme RK
Expert Opin Drug Deliv; 2009 Aug; 6(8):865-78. PubMed ID: 19637974
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-based nanoparticles as delivery systems of therapeutic proteins.
Fonte P; Andrade JC; Seabra V; Sarmento B
Methods Mol Biol; 2012; 899():471-87. PubMed ID: 22735970
[TBL] [Abstract][Full Text] [Related]
12. Beta-casein and its complexes with chitosan as nanovehicles for delivery of a platinum anticancer drug.
Razmi M; Divsalar A; Saboury AA; Izadi Z; Haertlé T; Mansuri-Torshizi H
Colloids Surf B Biointerfaces; 2013 Dec; 112():362-7. PubMed ID: 24028849
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrin based nanosponges for pharmaceutical use: a review.
Tejashri G; Amrita B; Darshana J
Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles for parenteral delivery of actives.
Joshi MD; Müller RH
Eur J Pharm Biopharm; 2009 Feb; 71(2):161-72. PubMed ID: 18824097
[TBL] [Abstract][Full Text] [Related]
16. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
Talekar M; Kendall J; Denny W; Garg S
Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review.
Sultana S; Khan MR; Kumar M; Kumar S; Ali M
J Drug Target; 2013 Feb; 21(2):107-25. PubMed ID: 22873288
[TBL] [Abstract][Full Text] [Related]
18. Challenges to macromolecular drug delivery.
Juliano R
Biochem Soc Trans; 2007 Feb; 35(Pt 1):41-3. PubMed ID: 17233596
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances in liposomes and nanoparticles as drug carriers for drug delivery].
Liu Y; Lü WL; Zhang Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):583-9. PubMed ID: 16995319
[TBL] [Abstract][Full Text] [Related]
20. A novel lactoferrin-modified β-cyclodextrin nanocarrier for brain-targeting drug delivery.
Ye Y; Sun Y; Zhao H; Lan M; Gao F; Song C; Lou K; Li H; Wang W
Int J Pharm; 2013 Dec; 458(1):110-7. PubMed ID: 24126038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
